Offering will be conducted by agent H.C. Wainwright at $5.05 per share
By Devika Patel
Knoxville, Tenn., Oct. 7 – Northwest Biotherapeutics, Inc. said it will raise about $11.5 million in a private placement of stock. H.C. Wainwright & Co., LLC is the agent.
The company will sell common shares at $5.05 apiece. The price per share is a 0.4% premium to the Oct. 6 closing share price of $5.03.
Settlement is expected Oct. 10.
Northwest is a development-stage biotechnology company based in Bethesda, Md.
| Issuer: | Northwest Biotherapeutics, Inc.
|
| Issue: | Common shares
|
| Amount: | $11.5 million (approximate)
|
| Price: | $5.05
|
| Warrants: | No
|
| Agent: | H.C. Wainwright & Co., LLC
|
| Pricing date: | Oct. 7
|
| Settlement date: | Oct. 10
|
| Stock symbol: | Nasdaq: NWBO
|
| Stock price: | $5.03 at close Oct. 6
|
| Market capitalization: | $282.05 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
